PHARMACOKINETICS OF FLUOROPYRIMIDINES - IMPLICATIONS FOR THEIR CLINICAL USE

被引：93

作者：

MYERS, CE

DIASIO, R

ELIOT, HM

CHABNER, BA

机构：

[1] NCI,DIV CANC TREATMENT,MED BRANCH,BETHESDA,MD 20014

[2] NCI,DIV CANC TREATMENT,CHEM PHARMACOL LAB,BETHESDA,MD 20014

来源：

关键词：

D O I：

10.1016/S0305-7372(76)80021-7

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：175 / 183

页数：9

共 66 条

[1]

ALDRIDGE WN, 1972, FRONT BIOL, V26, P91

[2]

ANSFIELD FJ, 1971, CANCER-AM CANCER SOC, V28, P1147, DOI 10.1002/1097-0142(1971)28:5<1147::AID-CNCR2820280510>3.0.CO

[3]

2-L

[4]

BATEMAN JR, 1971, CANCER-AM CANCER SOC, V28, P907, DOI 10.1002/1097-0142(1971)28:4<907::AID-CNCR2820280414>3.0.CO

[5]

2-9

[6]

BOURKE RS, 1973, CANCER RES, V33, P1735

[7]

BRUCKNER HW, 1974, CANCER, V33, P14, DOI 10.1002/1097-0142(197401)33:1<14::AID-CNCR2820330106>3.0.CO

[8]

2-3

[9]

CARTER SK, 1972, CANCER-AM CANCER SOC, V30, P1543, DOI 10.1002/1097-0142(197212)30:6<1543::AID-CNCR2820300621>3.0.CO

[10]

2-V